NCT07203872View on ClinicalTrials.gov

Inflammation-resolution Therapy in MINST of Periodontal Intrabony Defect: a Pilot Randomised Controlled Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

May 1, 2027

Study Completion Date

May 1, 2027

Conditions
Periodontal DiseasesPeriodontitis
Interventions
DEVICE

IsoDent Paro Strong (Isodent Ltd. Valtakatu 4 D, 96100 Rovaniemi, Finland) mouthwash

adjunctive anti-inflammatory mouthwash

DEVICE

Placebo mouthwash

Contains all the inactive ingredients as the test mouthwash without the LXA4

Trial Locations (1)

SE1 9RT

Oral Clinical Research Unit (OCRU) at King's College London (KCL), London

All Listed Sponsors
collaborator

King's College London

OTHER

lead

Guy's and St Thomas' NHS Foundation Trust

OTHER

NCT07203872 - Inflammation-resolution Therapy in MINST of Periodontal Intrabony Defect: a Pilot Randomised Controlled Trial | Biotech Hunter | Biotech Hunter